Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of inflammatory bowel diseases
3.2.1.2 Rising incidence of anal fistulas
3.2.1.3 Technological advancements in surgical procedures
3.2.1.4 Growing aging population
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with the procedure
3.2.2.2 Limited treatment options for complex cases
3.3 Growth potential analysis
3.4 Porter's analysis
3.4.1 Supplier power
3.4.2 Buyer power
3.4.3 Threat of new entrants
3.4.4 Threat of substitutes
3.4.5 Industry rivalry
3.5 PESTEL analysis
3.6 Reimburesemnt scenario
3.7 Regulatory landscape
3.8 Technological landscape
3.9 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Treatment Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Surgical
5.2.1 Fistulotomy
5.2.2 Seton technique
5.2.3 Ligation of the intersphincteric fistula tract (LIFT)
5.2.4 Advancement flap
5.2.5 Other surgical treatment types
5.3 Non-surgical/fibrin glue
5.4 Medication
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Intersphincteric fistula
6.3 Transsphincteric fistula
6.4 Suprasphincteric fistula
6.5 Extraphincteric fistula
6.6 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital
7.3 Ambulatory surgical centers
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 AbbVie
9.2 Becton, Dickinson and Company
9.3 Biolitec AG
9.4 Boston Scientific Corporation
9.5 Coloplast Group
9.6 Cook Medical
9.7 Gem srl
9.8 Integra LifeSciences Holdings Corporation
9.9 KARL STORZ SE & Co. KG
9.10 Medtronic plc
9.11 Teleflex Incorporated
9.12 Zydus Lifesciences Limited
